Specifically, the regulation of GLS2 mainly reverses mitophagy during the latent period of epilepsy by affecting the expression of PINK1, p62, LC3, and TOMM20, thereby reducing the occurrence of SLEs. The gene discussed is MAP1LC3A; the disease is epilepsy.